Reuters logo
BRIEF-GSK files regulatory submission in U.S. for COPD treatment
2016年11月21日 / 早上7点11分 / 1 年前

BRIEF-GSK files regulatory submission in U.S. for COPD treatment

Nov 21 (Reuters) - Glaxosmithkline Plc

* Files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with copd

* This follows announcement earlier this year of plans to bring forward timing of us filing from first half of 2018. Source text for Eikon: Further company coverage: (Reporting By UK Bureau)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below